{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [
    [
      "NF-\u03baB",
      "SARS-CoV-2 ORF3a",
      "TRAF proteins",
      "inflammation"
    ]
  ],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "38005906",
  "DateCompleted": {
    "Year": "2023",
    "Month": "12",
    "Day": "18"
  },
  "DateRevised": {
    "Year": "2023",
    "Month": "12",
    "Day": "18"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2023",
        "Month": "11",
        "Day": "08"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "2229",
      "10.3390/v15112229"
    ],
    "Journal": {
      "ISSN": "1999-4915",
      "JournalIssue": {
        "Volume": "15",
        "Issue": "11",
        "PubDate": {
          "Year": "2023",
          "Month": "Nov",
          "Day": "08"
        }
      },
      "Title": "Viruses",
      "ISOAbbreviation": "Viruses"
    },
    "ArticleTitle": "SARS-CoV-2 ORF3a-Mediated NF-\u03baB Activation Is Not Dependent on TRAF-Binding Sequence.",
    "Abstract": {
      "AbstractText": [
        "Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has caused a global pandemic of Coronavirus Disease 2019 (COVID-19). Excessive inflammation is a hallmark of severe COVID-19, and several proteins encoded in the SARS-CoV-2 genome are capable of stimulating inflammatory pathways. Among these, the accessory protein open reading frame 3a (ORF3a) has been implicated in COVID-19 pathology. Here we investigated the roles of ORF3a in binding to TNF receptor-associated factor (TRAF) proteins and inducing nuclear factor kappa B (NF-\u03baB) activation. X-ray crystallography and a fluorescence polarization assay revealed low-affinity binding between an ORF3a N-terminal peptide and TRAFs, and a dual-luciferase assay demonstrated NF-\u03baB activation by ORF3a. Nonetheless, mutation of the N-terminal TRAF-binding sequence PIQAS in ORF3a did not significantly diminish NF-\u03baB activation in our assay. Our results thus suggest that the SARS-CoV-2 protein may activate NF-\u03baB through alternative mechanisms."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [
          "0000-0002-3030-211X"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Pathology, School of Medicine, Case Western Reserve University, Cleveland, OH 44106, USA."
          }
        ],
        "LastName": "Busscher",
        "ForeName": "Brianna M",
        "Initials": "BM"
      },
      {
        "Identifier": [
          "0000-0002-1036-5092"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Physiology and Biophysics, School of Medicine, Case Western Reserve University, Cleveland, OH 44106, USA."
          }
        ],
        "LastName": "Befekadu",
        "ForeName": "Henock B",
        "Initials": "HB"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Pathology, School of Medicine, Case Western Reserve University, Cleveland, OH 44106, USA."
          },
          {
            "Identifier": [],
            "Affiliation": "MOE Key Laboratory for Membraneless Organelles and Cellular Dynamics, Hefei National Research Center for Physical Sciences at the Microscale, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei 230027, China."
          }
        ],
        "LastName": "Liu",
        "ForeName": "Zhonghua",
        "Initials": "Z"
      },
      {
        "Identifier": [
          "0000-0001-9688-475X"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Pathology, School of Medicine, Case Western Reserve University, Cleveland, OH 44106, USA."
          }
        ],
        "LastName": "Xiao",
        "ForeName": "Tsan Sam",
        "Initials": "TS"
      }
    ],
    "GrantList": [
      {
        "GrantID": "P01 AI141350",
        "Acronym": "AI",
        "Agency": "NIAID NIH HHS",
        "Country": "United States"
      },
      {
        "GrantID": "R01 GM127609",
        "Acronym": "GM",
        "Agency": "NIGMS NIH HHS",
        "Country": "United States"
      },
      {
        "GrantID": "P01AI141350",
        "Acronym": "NH",
        "Agency": "NIH HHS",
        "Country": "United States"
      },
      {
        "GrantID": "R01GM127609",
        "Acronym": "NH",
        "Agency": "NIH HHS",
        "Country": "United States"
      }
    ],
    "PublicationTypeList": [
      "Journal Article"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "Switzerland",
    "MedlineTA": "Viruses",
    "NlmUniqueID": "101509722",
    "ISSNLinking": "1999-4915"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "NF-kappa B"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "ORF3a protein, SARS-CoV-2"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Viroporin Proteins"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "metabolism",
        "virology"
      ],
      "DescriptorName": "COVID-19"
    },
    {
      "QualifierName": [
        "metabolism"
      ],
      "DescriptorName": "NF-kappa B"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Protein Binding"
    },
    {
      "QualifierName": [
        "genetics",
        "metabolism"
      ],
      "DescriptorName": "SARS-CoV-2"
    },
    {
      "QualifierName": [
        "metabolism"
      ],
      "DescriptorName": "Viroporin Proteins"
    }
  ],
  "CoiStatement": "The authors declare no conflict of interest."
}